One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Assessing adherence to inhaled therapies in asthma and the emergence of electronic monitoring devices
Hetal Dhruve, David J. Jackson
doi : 10.1183/16000617.0271-2021
30 June 2022; volume 31, issue 164
Infrequent use of inhaled corticosteroids (ICS) and/or over-reliance of short-acting β-agonists (SABA) are recognised as key contributors to increased morbidity and mortality in asthma. The most frequent measures of ICS adherence and SABA use rely on patient-reported questionnaires or prescription refill records, neither of which are considered sufficiently reliable.
COVID-19 and tuberculosis: the double whammy of respiratory pathogens
Mohd Shariq, Javaid A. Sheikh, Neha Quadir, Neha Sharma, Seyed E. Hasnain, Nasreen Z. Ehtesham
doi : 10.1183/16000617.0264-2021
Prior to coronavirus disease 2019 (COVID-19), tuberculosis (TB) was the worst killer among infectious diseases. The union of these two obnoxious respiratory diseases can be devastating, with severe public health implications.
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis
Nardin Hanna, Youstina Hanna, Henrietta Blinder, Julia Bokhaut, Sherri L. Katz
doi : 10.1183/16000617.0026-2022
Children with Down syndrome are at increased risk of sleep disordered breathing (SDB). SDB is associated with significant morbidity including neurocognitive impairment, cardiometabolic disease and systemic inflammation.
Pathogenesis of tuberculosis: the 1930 Lübeck disaster revisited
Peter Donald, Stefan Kaufmann, Stephanie Thee, Anna Maria Mandalakas, Christoph Lange
Risk factors for asthma exacerbations during pregnancy: a systematic review and meta-analysis
Annelies L. Robijn, Marleen P. Bokern, Megan E. Jensen, Daniel Barker, Katherine J. Baines, Vanessa E. Murphy
Practical recommendations to combine small-molecule inhibitors and direct oral anticoagulants in patients with nonsmall cell lung cancer
Leila S. Otten, Berber Piet, Michel M. van den Heuvel, Catia Marzolini, Robin M.J.M. van Geel, Judith L. Gulikers, David M. Burger, Jenneke Leentjens, Rob ter Heine
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD
Yaw-Syan Fu, Ning Kang, Yanping Yu, Yan Mi, Jialin Guo, Jingyi Wu, Ching-Feng Weng
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis
Diana H. Quan, Alexander J. Kwong, Philip M. Hansbro, Warwick J. Britton
End-point definition and trial design to advance tuberculosis vaccine development
Alberto L. Garcia-Basteiro, Richard G. White, Dereck Tait, Alexander C. Schmidt, Molebogeng X. Rangaka, Matthew Quaife, Elisa Nemes, Robin Mogg, Philip C. Hill, Rebecca C. Harris, Willem A. Hanekom, Mike Frick, Andrew Fiore-Gartland, Tom Evans, Alemnew F. Dagnew, Gavin Churchyard, Frank Cobelens, Marcel A. Behr, Mark Hatherill
Biologics in severe asthma: the role of real-world evidence from registries
Giovanni Paoletti, Jack Pepys, Marta Casini, Danilo Di Bona, Enrico Heffler, Celine Y.Y. Goh, David B. Price, Giorgio Walter Canonica
Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome
Hélène Pailhoriès, Jean-Louis Herrmann, Lourdes Velo-Suarez, Claudie Lamoureux, Clémence Beauruelle, Pierre-Régis Burgel, Geneviève Héry-Arnaud
Investigation and management of residual sleepiness in CPAP-treated patients with obstructive sleep apnoea: the European view
Sonya Craig, Jean-Louis Pépin, Winfried Randerath, Christian Caussé, Johan Verbraecken, Jerryll Asin, Ferran Barbé, Maria R. Bonsignore
Bidirectional relationships of comorbidity with obstructive sleep apnoea
Margaret Gleeson, Walter T. McNicholas
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell
Jason L.N. Girkin, Steven Maltby, Nathan W. Bartlett
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Cristina Zappa, Gian Marco Manzetti, Andrea Perduno, Janis Shute, Paola Rogliani
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents
Elise Belaidi, Charles Khouri, Olfa Harki, Sébastien Baillieul, Gilles Faury, Anne Briançon-Marjollet, Jean-Louis Pépin, Claire Arnaud
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives
Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin, Athol U. Wells
Correspondence regarding “Ventilatory efficiency in athletes, asthma and obesity�: different ventilatory phenotypes during exercise in obesity?
Nicola Borasio, Marco Vecchiato, Giulia Quinto, Francesca Battista, Daniel Neunhaeuserer, Andrea Ermolao
Reply to: “Ventilatory efficiency in athletes, asthma and obesity�: different ventilatory phenotypes during exercise in obesity?
Sophie É. Collins, Devin B. Phillips, Andrew R. Brotto, Zahrah H. Rampuri, Michael K. Stickland
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients
Gurgen Harutyunyan, Varsenik Harutyunyan, Garnik Harutyunyan, Andrés Sánchez Gimeno, Artur Cherkezyan, Spartak Petrosyan, Anatoli Gnuni, Suren Soghomonyan
Hypoxaemia in COVID-19: many pieces to a complex puzzle
Mattia Busana, Luigi Camporota, Luciano Gattinoni
“Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives�. Sara Tomassetti, Venerino Poletti, Claudia Ravaglia, Nicola Sverzellati, Sara Piciucchi, Diletta Cozzi, Valentina Luzzi, Camilla Comin and Athol U. Wells. Eur Respir Rev 2022; 31: 210206.
